Sept 25 (Reuters) - N2OFF Inc ( NITO ):
* N2OFF STOCKHOLDERS APPROVE MERGER WITH DRUG DISCOVERY
COMPANY
TARGETING RESISTANT CANCERS INCLUDING PANCREATIC AND NON-SMALL
CELL LUNG CANCER
Source text:
Further company coverage: